Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates

Complete response (CR) rates reported for cytotoxic chemotherapy for late-stage cancer patients are generally low, with few exceptions, regardless of the solid cancer type or drug regimen. We investigated CR rates reported in the literature for clinical trials using chemotherapy alone, across a wide...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashdown, Martin L., Robinson, Andrew P., Yatomi-Clarke, Steven L., Ashdown, M. Luisa, Allison, Andrew, Abbott, Derek, Markovic, Svetomir N., Coventry, Brendon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2015
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706056/
https://www.ncbi.nlm.nih.gov/pubmed/26834979
http://dx.doi.org/10.12688/f1000research.6760.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706056/
https://www.ncbi.nlm.nih.gov/pubmed/26834979
http://dx.doi.org/10.12688/f1000research.6760.1

Ejemplares similares